Earnings History Data for Mirati Therapeutics (MRTX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Mirati Therapeutics

Mirati Therapeutics, Inc. is a biopharmaceutical company. It engaged in the development of novel therapeutics for the treatment of cancer. Mirati Therapeutics, Inc., formerly known as MethylGene Inc., is based in Montreal, Canada.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
06-11-2023 PM MRTX Mirati Therapeutics 3,264 -2.49 -2.92 0.00 Mirati Therapeutics GAAP EPS of -$2.49 beats by $0.40, revenue of $16.4M misses by $2.83M
[11/6/2023 11:48 AM]
56.26 0.24 
(0.43%)
0.0 0.0 
(0.00%)
27.30 - 101.30 840,718 1,350,000 0
08-08-2023 AH MRTX Mirati Therapeutics, Inc. 1,710 -3.04 -3.23 -3.18 Mirati Therapeutics GAAP EPS of -$3.04 beats by $0.17, revenue of $13.69M beats by $0.07M
[8/8/2023 4:48 PM]
37.07 9.27 
(33.35%)
33.98 6.18 
(22.23%)
27.30 - 101.30 6,822,219 1,090,000 148,722
09-05-2023 AH 4:10 PM ET
(May 9)
MRTX Mirati Therapeutics, Inc. 2,670 -3.18 -3.47 -3.40 Mirati Therapeutics GAAP EPS of -$3.18 beats by $0.41, revenue of $7.17M beats by $2.37M
[5/9/2023 4:30 PM]
47.95 0.64 
(1.35%)
46.90 -0.41 
(-0.87%)
32.96 - 101.30 1,067,270 840,000 5,966
28-02-2023 AH 4:10 PM ET
(Feb 28)
MRTX Mirati Therapeutics, Inc. 2,650 -3.51 -3.74 -3.72 Mirati Therapeutics GAAP EPS of -$3.51 beats by $0.16, revenue of $0.93M misses by $1.72M
[2/28/2023 4:41 PM]
44.97 -0.87 
(-1.90%)
46.75 0.91 
(1.99%)
32.96 - 101.30 904,720 850,000 149,465
08-11-2022 AH 4:00 PM ET
(Nov 8)
MRTX Mirati Therapeutics, Inc. 3,520 -3.09 -3.46 -1.55 Mirati Therapeutics GAAP EPS of -$3.09 beats by $0.40, revenue of $5.4M beats by $4.03M
[11/8/2022 4:24 PM]
62.01 2.57 
(4.32%)
59.44 0.0 
(0.00%)
32.96 - 175.50 1,281,054 700,000 2,947
03-08-2022 AH 4:00 PM ET
(Aug 3)
MRTX Mirati Therapeutics, Inc. 3,770 -3.18 -3.53 -3.23 Mirati Therapeutics GAAP EPS of -$3.18 beats by $0.32, revenue of $5.36M beats by $4.98M
[8/3/2022 4:22 PM]
77.87 6.09 
(8.48%)
3.92 -0.40 
(-9.26%)
32.96 - 195.99 842,284 1,040,000 51,552
04-05-2022 AH 4:00 PM ET
(May 4)
MRTX Mirati Therapeutics 3,430 -3.40 -3.37 0.00 Mirati Therapeutics GAAP EPS of -$3.40 beats by $0.17, revenue of $0.71M beats by $0.53M
[5/4/2022 4:41 PM]
62.39 -1.63 
(-2.55%)
64.02 0.0 
(0.00%)
60.50 - 195.99 989,144 740,000 7,312
28-02-2022 AH 4:00 PM ET
(Feb 28)
MRTX Mirati Therapeutics, Inc. 4,860 -3.72 -3.01 -2.08 90.18 1.89 
(2.14%)
88.29 0.0 
(0.00%)
81.54 - 207.07 618,287 1,110,000 185,327
08-11-2021 AH 4:15 PM ET
(Nov 8)
MRTX Mirati Therapeutics, Inc. 8,640 -1.55 -2.87 -1.96 Mirati Therapeutics EPS beats by $1.47, beats on revenue
[11/8/2021 4:06 PM]
168.04 8.13 
(5.08%)
170.00 10.09 
(6.31%)
131.47 - 249.42 702,490 460,000 15,682
06-05-2021 AH 4:15 PM ET
(May 6)
MRTX Mirati Therapeutics, Inc. 7,980 -2.67 -2.13 -2.02 Mirati Therapeutics EPS misses by $0.54
[5/6/2021 5:24 PM]
144.00 -6.77 
(-4.49%)
150.77 0.0 
(0.00%)
91.90 - 249.42 1,672,399 780,000 370,202
04-11-2020 AH MRTX Mirati Therapeutics, Inc. 9,626 -1.96 -2.04 0.00 Mirati Therapeutics EPS beats by $0.07
[11/4/2020 5:46 PM]
236.36 1.68 
(0.72%)
234.68 0.0 
(0.00%)
66.01 - 240.58 330,488 986,485 15,910